Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The aim of this study was to compare the 30-day procedural, clinical and echocardiographic
outcome of the new balloon-expandable Edwards Sapien 3 (ES3) valve with the Edwards
Sapien XT (ESXT).